Program | Grantee | Infrastructure Related Project | Total Award | Year of Award | Status at End of FY 2025 |
Workforce Development Capital | American International College | Life Sciences Lab Improvements | $499,526 | FY 2024 | Completed |
Capital Program | Bay Path College | Planning Grant | $50,000 | FY 2013 | Completed |
Capital Program | Bay Path University | Equipment for Workforce Training | $499,996 | FY 2015 | Completed |
Capital Program | Baystate Health | Clinical Trials Unit | $3,949,912 | FY 2019 | Completed |
Capital Program | Baystate Medical Center | Health Informatics and Technology Innovation Center (HITIC) | $5,500,000 | FY 2013 | Completed |
Women's Health | Baystate Medical Center | Evaluation of novel biomarkers for the early detection of ovarian and breast cancer | $456,861 | FY 2023 | Completed |
Workforce Capital | Benjamin Franklin Cummings Institute of Technology | Biotechnology Program | $241,408 | FY 2022 | Completed |
Capital Program | Berkshire Community College | Equipment for Workforce Training | $499,998 | FY 2015 | Completed |
Capital Program | Berkshire Innovation Center | Life Sciences Incubator - Berkshire Innovation Center (BIC) | $11,970,000 | FY 2018 | Completed |
Capital Program | Beth Israel Deaconess Medical Center | Organ on chip facility in a hospital setting | $1,705,471 | FY 2020 | Completed |
Women's Health | Beth Israel Deaconess Medical Center | The Lactation Lab: Improving the health of two generations by optimizing breastfeeding | $857,317 | FY 2020 | Completed |
Bits to Bytes | Beth Israel Deaconess Medical Center | Creating a Large Clinically Annotated Dataset of Antibody and TCR Repertoires in Cancer and Infectious Disease | $684,394 | FY 2021 | Completed |
Women's Health Innovation | Beth Israel Deaconess Medical Center | Develop first in class agents that mitigate the underlying causes of preeclampsia | $110,000 | FY 2021 | Completed |
Bits to Bytes | Beth Israel Deaconess Medical Center | Advance the development of diagnostic and prognostic biomarkers for NASH | $750,000 | FY 2022 | Completed |
Capital Program | Beth Israel Deaconess Medical Center | Innovative Glycoscience for Diagnostic and Therapeutic Advances | $1,401,046 | FY 2022 | Completed |
Novel Therapeutics Delivery | Beth Israel Deaconess Medical Center | Hepatocyte-specific delivery of RNA therapy for liver failure | $746,460 | FY 2022 | Completed |
Novel Therapeutics Delivery | Beth Israel Deaconess Medical Center | SARS-CoV-2 Variants, Viral Pneumonia, Encephalitis, Sentinel Discovery, Diagnostics and Technology Evaluation | $749,687 | FY 2022 | Completed |
Bits to Bytes | Beth Israel Deaconess Medical Center | Echocardiogram and electrocardiogram extension to the MIMIC database | $636,938 | FY 2020 | Completed |
Capital Program | Beth Israel Deaconess Medical Center | Spatial Technologies Unit in the Precision Medicine Initiative at BIDMC | $3,307,756 | FY 2021 | Completed |
Bits to Bytes | Beth Israel Deaconess Medical Center | Advance the development of diagnostic and prognostic biomarkers for NASH | $750,000 | FY 2024 | *Ongoing |
Novel Therapeutics Delivery | Beth Israel Deaconess Medical Center | Development of novel active and programmable scaffolds for targeted therapeutic agent delivery in chronic wounds | $750,000 | FY 2024 | *Ongoing |
Novel Therapeutics Delivery | Beth Israel Deaconess Medical Center | Immune-mediated HBV viral clearance: In-Depth In Situ Analysis of Vaccine-Induced, HBV-Specific T Cells Targeting Infected Liver Organoids | $750,000 | FY 2024 | *Ongoing |
Women's Health Innovation | Beth Israel Deaconess Medical Center | Non-invasive Point-Of-Care Hemoglobin Testing in Pregnancy | $47,400 | FY 2024 | *Ongoing |
Women's Health Innovation | Beth Israel Deaconess Medical Center | Assessment of Left Ventricular Ejection Fraction in Pregnant and Postpartum Patients Using a Novel Handheld Ultrasound Device with AI-Assisted Algorithm | $158,200 | FY 2024 | *Ongoing |
Women's Health Innovation | Beth Israel Deaconess Medical Center | Second generation dual-function redox modulators for Preeclampsia therapy | $200,000 | FY 2024 | *Ongoing |
Women's Health Innovation | Beth Israel Deaconess Medical Center | In the heat of the cycle: The missing piece of female reproductive control | $200,000 | FY 2025 | *Ongoing |
Research Infrastructure | Beth Israel Deaconess Medical Center | MassNano | $1,807,465 | FY 2025 | *Ongoing |
Women's Health Innovation | Beth Israel Deaconess Medical Center | Novel organofluorine hydrazones targeting oxidative stress for Preeclampsia treatment | $200,000 | FY 2025 | *Ongoing |
Capital Program | BioBuilder Educational Foundation, Inc. | Learning Lab at LabCentral | $500,000 | FY 2017 | *Ongoing |
Workforce Development Capital | BioBuilder Educational Foundation, Inc. | BioTechBuilder Learning Lab @ Allston | $390,198 | FY 2024 | Completed |
Bits to Bytes | Boston Children’s Hospital | Precision Nutrition for Term-born Infants | $749,950 | FY 2021 | Completed |
Research Infrastructure | Boston Children’s Hospital | Stem Cell Imaging and Therapeutics Center | $2,557,526 | FY 2024 | Completed |
Women's Health Innovation | Boston Children’s Hospital | Personalized bacterial vaginosis (BV) Treatments: Harnessing Organ Chip Models to Tackle Health Inequity | $200,000 | FY 2024 | *Ongoing |
Women's Health Innovation | Boston Children’s Hospital | Anti capillary morphogenesis gene 2 (CMG2) camelid antibodies as diagnostics and therapeutics for endometriosis | $200,000 | FY 2025 | *Ongoing |
Capital Program | Boston Children's Hospital | Cell Therapy Center Improvements | $4,014,031 | FY 2013 | Completed |
Capital Program | Boston Children's Hospital | Human Neuron Core Improvements | $2,263,133 | FY 2015 | Completed |
Bits to Bytes | Boston Children's Hospital | Subcellular Dynamics | $658,167 | FY 2019 | Completed |
Capital Program | Boston Children's Hospital | Center for Accelerated Therapeutic Development | $1,523,992 | FY 2019 | Completed |
Women's Health Innovation | Boston Medical Center | Non-hormonal female contraceptive | $191,466 | FY 2021 | Completed |
Women's Health Innovation | Boston Medical Center | Refining a novel, non-hormonal, long-acting female contraceptive device | $200,000 | FY 2023 | Completed |
Capital Program | Boston University | Biomedical Lab and Clinical Sciences Program | $180,000 | FY 2015 | Completed |
Novel Therapeutics Delivery | Boston University | Glycosylation analysis techniques and software to enable generation of more effective Influenza A virus vaccines | $749,349 | FY 2020 | Completed |
Women's Health Innovation | Boston University | Development of novel breast cancer therapies by targeting epigenetic dysregulation in tumors | $195,094 | FY 2021 | Completed |
Novel Therapeutics Delivery | Boston University | Advancing the delivery of genome editors with next-generation non-viral delivery systems | $750,000 | FY 2024 | *Ongoing |
Women's Health Collaboration | Boston University | Novel Biosensors for Monitoring Fertility at the Point of Care | $805,660 | FY 2024 | *Ongoing |
Capital Program | Boston University | Business Innovation Center (BIC) at the BU Photonics Center | $363,750 | FY 2015 | Completed |
Workforce Development Capital | Boston University | BRIDGES: Biomedical Research to Industry Development, Growth, Engineering, and Scale-up | $750,000 | FY 2025 | *Ongoing |
Bits to Bytes | Boston University | Blood-Based Diagnostics from Circulating Cell-Free Nucleic Acid | $749,979 | FY 2025 | *Ongoing |
Capital Program | Boston University Medical School | Center for Translational Neurotrauma Imaging | $4,896,000 | FY 2019 | Completed |
Capital Program | Boston University Medical School | Lung Regeneration Initiative (LRI) Stem Cell Facility | $1,743,648 | FY 2015 | Completed |
Research Infrastructure | Brandeis University | High-speed imaging and superresolution imaging of organs, tissues, cells, and molecules for Massachusetts Research Corridors | $2,538,729 | FY 2025 | *Ongoing |
Workforce Capital | Bridgewater State University | Biological Sciences | $623,400 | FY 2023 | Completed |
Capital Program | Brigham and Women’s Hospital | High Field Mass Spectometry | $5,000,000 | FY 2019 | Completed |
Capital Program | Brigham and Women’s Hospital | Enabling Computational and Quantitative Microbiology to Promote Commonwealth Innovation | $3,346,155 | FY 2022 | Completed |
Capital Program | Brigham and Women’s Hospital | MAGNUS – next-generation MRI scanner to advance brain research in Massachusetts | $3,026,942 | FY 2022 | Completed |
Women's Health | Brigham and Women’s Hospital | The Multiomic Multiple Sclerosis Brain | $748,114 | FY 2022 | Completed |
Bits to Bytes | Brigham and Women's Hospital | Artificial Intelligence Guidance for High-Yield Point-of-Care Ultrasound Applications | $740,940 | FY 2021 | Completed |
Capital Program | Brigham and Women's Hospital | Ultrahigh-Resolution Molecular Imaging for Accelerated Drug Development | $2,402,909 | FY 2023 | Completed |
Bits to Bytes | Brigham and Women's Hospital | Advancing Point-of-Care Ultrasound Imaging through Deep Learning Model Development | $750,000 | FY 2024 | *Ongoing |
Capital Program | Brigham and Women's Hospital | Host-Microbiome Center | $2,603,537 | FY 2015 | Completed |
Bits to Bytes | Brigham and Women's Hospital | Natural History of Neurofilament Concentrations and Mechanisms of Healthy Aging | $728,559 | FY 2020 | Completed |
Women's Health | Brigham and Women's Hospital | The Lactation Lab: Improving the health of two generations by optimizing breastfeeding | $267,647 | FY 2020 | Completed |
Bits to Bytes | Brigham and Women's Hospital | Serum miRNA | $750,000 | FY 2019 | Completed |
Bits to Bytes | Brigham and Women's Hospital | Deep molecular profile of in vivo glioblastoma response to multiple, individual drugs simultaneously as a clinical data set to support development of drugs targeting brain cancer | $748,065 | FY 2023 | *Ongoing |
Women's Health Innovation | Brigham and Women's Hospital | Personalized 3D-Printed Breast Molds for Reconstruction Surgery in Mastectomy Patients Using Mixed Reality Technology | $99,508 | FY 2025 | *Ongoing |
Women's Health Innovation | Brigham and Women's Hospital | Development of a Novel Closed-Loop Infusion System for Vasopressor Administration in Pregnant Patients Presenting for Cesarean Delivery | $48,000 | FY 2025 | *Ongoing |
Bits to Bytes | Brigham and Women's Hospital & BIDMC | The Perinatal Systems Biology Program: Leveraging data science and multi-omics approaches for the health of two generations | $762,616 | FY 2023 | *Ongoing |
Capital Program | Bristol Community College | Cleanroom-like suite educational space | $4,400,000 | FY 2017 | Completed |
Workforce Capital | Bristol Community College | Analytical Chemistry Training Laboratory | $525,225 | FY 2022 | Completed |
Bits to Bytes | Broad Institute | Cell Painting | $821,000 | FY 2019 | Completed |
Bits to Bytes | Broad Institute | Data driven approaches to cardio diseases | $750,000 | FY 2019 | Completed |
Bits to Bytes | Broad Institute | OASIS: Exploring Cell Painting and -omics for Liver Toxicity Assessment | $1,011,039 | FY 2023 | *Ongoing |
Workforce Development Capital | Bunker Hill Community College | AS in Biological Sciences Program | $444,081 | FY 2024 | Completed |
Capital Program | Bunker Hill Community College | Equipment for Workforce Training | $200,000 | FY 2013 | Completed |
Capital Program | Cape Cod Community College | Equipment for Workforce Training | $394,912 | FY 2014 | Completed |
Workforce Capital | Cape Cod Community College | AA Biology/Biotechnology Certificate | $221,191 | FY 2022 | Completed |
Capital Program | City of Taunton | Development of Life Sciences Center in City of Taunton | $55,000 | FY 2014 | Completed |
Workforce Capital | Clark University | Chemistry & Biochemistry | $746,872 | FY 2023 | Completed |
Workforce Development Capital | Curry College | Data Science Lab | $495,030 | FY 2025 | *Ongoing |
Capital Program | Dana Farber Cancer Institute | Establish an immunotherapy platform for antibody and CAR therapeutics discovery<br />and translation | $2,713,670 | FY 2023 | Completed |
Women's Health | Dana Farber Cancer Institute | Optimizing the treatment in high-risk hormone receptor positive breast cancer through a multi-omic integrative holistic approach | $750,000 | FY 2023 | *Ongoing |
Capital Program | Dana-Farber Cancer Institute | Molecular Cancer Imaging Facility (MCIF) | $10,000,000 | FY 2012 | Completed |
Capital Program | Dana-Farber Cancer Institute | Advanced Cell Therapy Unit at the Cell Manipulation Core Facility | $4,629,019 | FY 2017 | Completed |
Capital Program | Dana-Farber Cancer Institute | Mass Spectrometry Metabolomics Solutions. Charting Metabolic Disease Development and Therapeutic Outcomes | $1,824,016 | FY 2021 | Completed |
Women's Health | Dana-Farber Cancer Institute | Leveraging Digital Pathology to Identify and Cure High Risk Breast Cancer | $748,075 | FY 2021 | Completed |
Women's Health Innovation | Dana-Farber Cancer Institute | Study of microbiome in relation to breast cancer and treatment options | $194,636 | FY 2021 | Completed |
Women's Health Innovation | Dana-Farber Cancer Institute | Microdevice to measure drug response in ovarian cancer patients | $98,359 | FY 2021 | Completed |
Capital Program | Dana-Farber Cancer Institute | Center for Emergent Drug Targets | $2,811,397 | FY 2022 | Completed |
Novel Therapeutics Delivery | Dana-Farber Cancer Institute | RNA/LNP delivery of optimized CAR for immunotherapy of cancer | $750,000 | FY 2024 | *Ongoing |
Workforce Development Capital | Dana-Farber Cancer Institute | Cell Therapy GxP Specialist Certificate Program | $357,380 | FY 2025 | *Ongoing |
Women's Health Innovation | Dana-Farber Cancer Institute | A Novel Treatment for Postmenopausal Osteoporosis in Women | $233,835 | FY 2025 | *Ongoing |
Bits to Bytes | Dana-Farber Cancer Institute | AI/ML with Spatial Transcriptomics to Identify Biomarkers of Response in Immunotherapy Treated Urothelial Carcinoma Patients | $750,000 | FY 2025 | *Ongoing |
Women's Health Collaboration | Dana-Farber Cancer Institute | Leveraging epigenetics to address resistance to PARP inhibitors in breast and gynecological cancers | $750,000 | FY 2025 | *Ongoing |
Capital Program | Dean College | Biology Laboratory Equipment | $297,030 | FY 2017 | Completed |
Workforce Capital | Dean College | Cell and Molecular Biology; New Chemistry lab | $615,489 | FY 2023 | Completed |
Workforce Development Capital | Dean College | Expanding Undergraduate Research and Program Management Experience | $627,582 | FY 2025 | *Ongoing |
Workforce Capital | Emmanuel College | CERTI-Biotech: Certified Employment Ready as Trained Instrumentalists | $574,376 | FY 2023 | Completed |
Workforce Capital | Fitchburg State University | Biotechnology and Bioinformatics | $710,660 | FY 2023 | Completed |
Capital Program | Framingham State University | Science Center Laboratories Renovation | $454,000 | FY 2017 | Completed |
Workforce Capital | Framingham State University | Biotechnology - NMR spectrometer and LC-Mass Spec | $496,195 | FY 2023 | Completed |
Workforce Development Capital | Framingham State University | Biotech Skills Lab Space and Increased Capacity | $446,562 | FY 2025 | *Ongoing |
Capital Program | Framingham State University | Hemenway Hall Science Center | $3,000,000 | FY 2014 | Completed |
Workforce Capital | Framingham State University | Professional Science Master’s (PSM) in Biotechnology, with concentration in Quality Assurance | $19,516 | FY 2022 | Completed |
Capital Program | Framingham Wastewater and Pumping Station | Pleasant Street Water Transmission Line | $12,860,534 | FY 2009 | Completed |
Capital Program | Gloucester Marine Genomics Institute | Marine Genomics Research Institute at Gloucester Harbor | $2,744,219 | FY 2017 | Completed |
Capital Program | Gloucester Marine Genomics Institute | Cell Culture Lab | $174,383 | FY 2019 | Completed |
Workforce Capital | Gloucester Marine Genomics Institute | Cell Culture | $99,197 | FY 2023 | Completed |
Workforce Capital | Gloucester Marine Genomics Institute | Biomanufacturing Expansion and Program Scale | $556,928 | FY 2022 | Completed |
Capital Program | Harvard Medical School | Laboratory of Systems Pharmacology expansion | $4,345,000 | FY 2017 | Completed |
Bits to Bytes | Harvard Medical School | Metabolomics and Big Data | $750,000 | FY 2019 | Completed |
Women's Health | Harvard Medical School | Pathfinder: Studying Lymphocyte Repertoire Dynamics During Pregnancy in Autoimmune Sufferers | $735,000 | FY 2021 | Completed |
Women's Health | Harvard Medical School | Improving selectivity of an MeCP2 exon-editor for Rett Syndrome | $750,000 | FY 2023 | *Ongoing |
Women's Health Innovation | Harvard Medical School | A Non-Invasive Approach to Diagnosis of Endometriosis | $200,000 | FY 2025 | *Ongoing |
Bits to Bytes | Harvard Medical School | Deep spatial profiling of solid tumors to improve health outcomes | $729,953 | FY 2025 | *Ongoing |
Capital Program | Harvard Medical School | Laboratory Systems of Pharmacology (LSP) | $4,999,921 | FY 2013 | Completed |
Workforce Development Capital | Harvard Medical School-MEDscience | MEDscience Workforce Development Program | $70,800 | FY 2024 | *Ongoing |
Capital Program | Harvard T.H. Chan School of Public Health | BioBank for Microbiome Research (BIOM-Mass) | $4,912,307 | FY 2017 | Completed |
Bits to Bytes | Harvard T.H. Chan School of Public Health | Microbiome in chronic disease management | $688,533 | FY 2019 | Completed |
Novel Therapeutics Delivery | Harvard T.H. Chan School of Public Health | Advancing CNS Therapeutic Delivery via ARMMs | $268,633 | FY 2020 | Completed |
Bits to Bytes | Harvard T.H. Chan School of Public Health | High Throughput Laboratory for Advanced Immunological Testing for Clinical and Public Health Surveillance | $737,950 | FY 2021 | Completed |
Capital Program | Harvard T.H. Chan School of Public Health | Create an advanced bioimaging center for pathogens in BSL3 containment | $1,850,084 | FY 2023 | Completed |
Women's Health Innovation | Harvard T.H. Chan School of Public Health | Microbial and Immune Correlates of Vaginal Beta-Carbolines | $199,964 | FY 2025 | *Ongoing |
Women's Health Innovation | Harvard University | Novel brain shuttle mediated anti-HER2 therapeutics for breast cancer brain metastasis | $200,000 | FY 2024 | *Ongoing |
Capital Program | Holyoke Community College | Center for Life Sciences | $3,800,000 | FY 2013 | Completed |
Capital Program | Holyoke Community College | Equipment for Workforce Training | $300,000 | FY 2015 | Completed |
Capital Program | Institute for Protein Innovation | Open-source Antibody Discovery platform | $5,000,000 | FY 2017 | Completed |
Workforce Capital | Jewish Vocational Service, Inc. | Bridges to College and Careers Biotechnology Pathway Expansion: Boston Healthcare and Life Sciences Career Institute | $582,821 | FY 2022 | Completed |
Capital Program | Joslin Diabetes Center | Translational Center for the Cure of Diabetes | $5,000,000 | FY 2012 | Completed |
Workforce Development Capital | Just A Start | Rindge Commons Economic Mobility Hub – Bioscience Lab | $200,191 | FY 2024 | Completed |
Workforce Capital | Just A Start | The Rindge Commons Economic Mobility Hub - Bioscience Lab | $740,970 | FY 2022 | Completed |
Capital Program | Just A Start | Equipment | $46,079 | FY 2014 | Completed |
Capital Program | Just A Start | Equipment | $49,992 | FY 2015 | Completed |
Capital Program | Lab Central 238 | Build-out facility to bridge gaps as startups design and test the processes prior to full-scale GMP production | $5,000,000 | FY 2019 | Completed |
Capital Program | LabCentral | Accelerator Lab | $4,955,515 | FY 2013 | Completed |
Capital Program | LabCentral | Accelerator Lab Expansion | $5,000,000 | FY 2014 | Completed |
Workforce Capital | LabCentral | LabCentral Ignite Career Forge Program | $319,757 | FY 2023 | Completed |
Capital Program | Lahey Hospital & Medical Center | Image-guided Therapy Innovation Center | $3,143,016 | FY 2022 | Completed |
Women's Health Innovation | Lahey Hospital & Medical Center | Define Gender-Specific Modifiers of Immune Predisposition to Long-haul COVID-19. | $162,698 | FY 2023 | Completed |
Workforce Capital | Lasell University | Virtual Reality and Artificial Intelligence Scientific Discovery | $744,629 | FY 2023 | Completed |
Workforce Capital | Lasell University | Life Science Program: Biochemistry and Biology Majors | $703,632 | FY 2022 | Completed |
Capital Program | MA Green High Performance Computing Center | Commonwealth Computational Cloud for Data Driven Biology Facility (C3DDB) | $4,540,000 | FY 2013 | Completed |
Capital Program | Marine Biological Laboratory | Building Capacity and a<br />Community for Correlative Imaging Technology in Southeastern Massachusetts | $4,350,011 | FY 2023 | Completed |
Capital Program | Marine Biological Laboratory in Woods Hole | Center for Regenerative Biology and Medicine | $10,000,000 | FY 2009 | Completed |
Workforce Capital | Mass College of Liberal Arts | Life Sciences at MCLA | $253,542 | FY 2022 | Completed |
Workforce Capital | Mass Maritime Academy | Instrumentation, Operation and Controls (IOC) Engineering Laboratory | $750,000 | FY 2022 | Completed |
Capital Program | Massachusetts Biomedical Initiatives | Expanding the Central MA Biomedical Infrastructure to Grow the Regional Cluster | $3,494,256 | FY 2019 | Completed |
Capital Program | Massachusetts Biomedical Initiatives | Expansion of Incubator Space | $500,000 | FY 2020 | Completed |
Capital Program | Massachusetts Biomedical Initiatives | MBI ScaleUp Center Expansion | $3,000,000 | FY 2022 | Completed |
Workforce Capital | Massachusetts College of Liberal Arts | Quality Control and Assurance (QC/A) Program; Biology and Chemistry | $625,550 | FY 2023 | Completed |
Workforce Capital | Massachusetts College of Pharmacy and Health Sciences | Pharmaceutical Sciences | $630,600 | FY 2022 | Completed |
Workforce Capital | Massachusetts College of Pharmacy and Health Sciences | Pharmaceutical Sciences and Toxicology | $747,762 | FY 2023 | Completed |
Workforce Development Capital | Massachusetts College of Pharmacy and Health Sciences | Life Science Development Workforce of the Future | $498,434 | FY 2024 | Completed |
Novel Therapeutics Delivery | Massachusetts Eye and Ear Infirmary | Optimization of the AAV manufacturing pipeline to produce better quality and higher yield recombinant AAV | $597,577 | FY 2023 | Completed |
Capital Program | Massachusetts General Hospital | Transforming Clinical Research for Brain Health | $4,805,000 | FY 2019 | Completed |
Bits to Bytes | Massachusetts General Hospital | An integrative platform to understand and exploit cancer metabolism | $750,000 | FY 2020 | Completed |
Novel Therapeutics Delivery | Massachusetts General Hospital | High resolution pharmacokinetics: imaging drug delivery from administration to on-target activity (high-res PK DATA) | $749,998 | FY 2020 | Completed |
Novel Therapeutics Delivery | Massachusetts General Hospital | Advancing CNS Therapeutic Delivery via ARMMs | $481,367 | FY 2020 | Completed |
Women's Health Innovation | Massachusetts General Hospital | Treatment of autoimmune conditions through CAR-T cells | $200,000 | FY 2021 | Completed |
Women's Health Innovation | Massachusetts General Hospital | Single-cell and multiomic approach to molecular and cellular ecosystem to understand women’s health conditions | $197,977 | FY 2021 | Completed |
Capital Program | Massachusetts General Hospital | Mass General Tumor Cartography Center | $3,633,519 | FY 2022 | Completed |
Novel Therapeutics Delivery | Massachusetts General Hospital | High-throughput translational microPET/CT imaging for radiotracer development and drug delivery | $749,670 | FY 2022 | Completed |
Novel Therapeutics Delivery | Massachusetts General Hospital | High-field MRI to enable development of diagnostics and therapeutics | $749,949 | FY 2023 | Completed |
Women's Health Innovation | Massachusetts General Hospital | Lead AMHR2 agonist selection for contraception and women's health | $200,000 | FY 2023 | Completed |
Research Infrastructure | Massachusetts General Hospital | Towards Integrative Medicine - Next-generation Whole-Body PET/CT to Study Interconnected Systems | $3,250,000 | FY 2024 | Completed |
Women's Health Innovation | Massachusetts General Hospital | Prediction of Pregnancy Outcomes Using Deep Learning Estimation of Cardiorespiratory Fitness (VO2 PEAK) | $80,849 | FY 2024 | *Ongoing |
Bits to Bytes | Massachusetts General Hospital | Facilitating drug development for neurodegenerative diseases | $666,500 | FY 2020 | Completed |
Bits to Bytes | Massachusetts General Hospital | Building an Immune Response Map for Antigen Prediction | $749,760 | FY 2025 | *Ongoing |
Novel Therapeutics Delivery | Massachusetts General Hospital | Rapid, Scalable, and Standardized Universal Antibody Screening Tests for AAV Gene Therapy | $750,000 | FY 2025 | *Ongoing |
Research Infrastructure | Massachusetts General Hospital | Mass General Human Tissue Living Biorepository (HTLB) | $3,379,000 | FY 2025 | *Ongoing |
Bits to Bytes | Massachusetts Institute of Technology | Echocardiogram and electrocardiogram extension to the MIMIC database | $358,918 | FY 2020 | Completed |
Novel Therapeutics Delivery | Massachusetts Institute of Technology | Regioselective conjugation of peptides to the major histocompatibility complex I (MHC I) | $747,427 | FY 2020 | Completed |
Capital Program | Massachusetts Institute of Technology | Technology Platform for Brain Research | $1,838,000 | FY 2015 | Completed |
NIIMBL | Massachusetts Institute of Technology | Blended Learning Cell Therapy Course | $330,200 | FY 2018 | Completed |
Building Breakthroughs | Massachusetts Institute of Technology | Model Predictive Control for Improved Product Quality in the Production of Viral Vectors- | $732,674 | FY 2019 | Completed |
Building Breakthroughs | Massachusetts Institute of Technology | Continuous Countercurrent Tangential Chromatography (CCTC) | $750,000 | FY 2019 | Completed |
NIIMBL | Massachusetts Institute of Technology | Viral Vaccines | $225,612 | FY 2019 | Completed |
NIIMBL | Massachusetts Institute of Technology | Small-scale Membrane-less Perfusion Bioreactor System | $267,182 | FY 2019 | Completed |
NIIMBL | Massachusetts Institute of Technology | Modularized PAT Online Training Platform to Accelerate the Workforce Innovation in Biopharmaceuticals Manufacturing | $264,164 | FY 2021 | Completed |
Women's Health | Massachusetts Institute of Technology | Nerve-immune Interactions as A Target of Endometriosis and Adenomyosis therapies | $665,000 | FY 2021 | Completed |
Women's Health Innovation | Massachusetts Institute of Technology | Increasing access to egg freezing through automation | $195,621 | FY 2021 | Completed |
Bits to Bytes | Massachusetts Institute of Technology | Integrating CRISPR-based screens with genetic risk data to elucidate CNS cell dysfunction in multiple sclerosis | $250,090 | FY 2022 | Completed |
Bits to Bytes | Massachusetts Institute of Technology | Decoding Complex Chronic Illness | $746,658 | FY 2023 | Completed |
NIIMBL | Massachusetts Institute of Technology | Integrated Continuous USP Platform for Maximum Productivity and Closed-loop controlled CQA | $61,099 | FY 2023 | Completed |
Women's Health Innovation | Massachusetts Institute of Technology | Sex differences in high resolution immune profiling of infection-associated chronic illness | $178,234 | FY 2023 | Completed |
Women's Health Innovation | Massachusetts Institute of Technology | Clinical assay development for TNBC patient stratification | $200,000 | FY 2023 | Completed |
Research Infrastructure | Massachusetts Institute of Technology | Enabling volume EM at the Cryo-EM Facility at MIT.nano | $3,050,588 | FY 2025 | *Ongoing |
Bits to Bytes | Massachusetts Institute of Technology | Decoding The Interplay Between Severe Allergies and Chronic Illness | $750,000 | FY 2025 | *Ongoing |
Workforce Development Capital | Massachusetts Maritime Academy | Natural & Life Science Laboratory Development | $500,000 | FY 2024 | Completed |
Workforce Development Capital | Massasoit Community College | Life Sciences Research Skills Micro-Credentialing Program | $253,128 | FY 2025 | *Ongoing |
Capital Program | MassBay Community College | Therapeutics and Genomics Training | $500,000 | FY 2019 | Completed |
Workforce Development Capital | MassBay Community College | Equipment to Strengthen the Biotechnology/Biomanufacturing Programs | $455,617 | FY 2024 | Completed |
Capital Program | MassBay Community College | Planning Grant | $43,920 | FY 2014 | Completed |
Workforce Capital | MassBay Community College | Center for Biotherapeutics and Genomics Training | $726,748 | FY 2022 | Completed |
NIIMBL | MassBiologics | Improve Lentiviral Vector Biomanufacturing for Cell and Gene Therapy Applications | $447,566 | FY 2018 | Completed |
NIIMBL | MassBiologics | Viral Vaccines | $185,540 | FY 2019 | Completed |
Capital Program | MassBiologics-UMass Chan Medical School | Vector Manufacturing Center (VMC) in Mattapan Facility | $5,000,000 | FY 2014 | Completed |
Women's Health Innovation | McLean Hospital | Evaluating the Impact of a Novel Cannabinoid Product for Endometriosis | $151,800 | FY 2024 | *Ongoing |
Capital Program | Merrimack College | Interdisciplinary Imaging and Analytical Science Equipment | $500,000 | FY 2017 | Completed |
Workforce Capital | Merrimack College | Life Sciences - Industry-Based Experiential Learning (LS-IBEL); Mass Spec | $749,911 | FY 2023 | Completed |
Workforce Development Capital | Middlesex Community College | Production/Maintenance Technician Training Program (PMTTP) | $750,000 | FY 2024 | Completed |
Capital Program | Middlesex Community College | Planning Grant | $36,664 | FY 2013 | Completed |
Capital Program | Middlesex Community College | Biotechnology Training Facility | $3,000,000 | FY 2014 | Completed |
Workforce Capital | Middlesex Community College | Biotechnology Technician (AS), Biology Transfer (AS) | $750,000 | FY 2022 | Completed |
Workforce Development Capital | Mount Holyoke College | Breaking Barriers in STEM Education: Modernizing Instrumentation to Empower Women and Gender-Diverse Scientists for Careers in Life Sciences | $590,602 | FY 2025 | *Ongoing |
Capital Program | Mount Wachusett Community College | Equipment for Workforce Training | $499,146 | FY 2014 | Completed |
Capital Program | Mount Wachusett Community College | Medical laboratory technology classroom | $1,646,725 | FY 2017 | Completed |
Capital Program | Museum of Science | Hall of Human Life Exhibit | $5,000,000 | FY 2012 | Completed |
Capital Program | Museum of Science | Race to the Vaccine Exhibition | $1,512,062 | FY 2021 | Completed |
Capital Program | New Bedford Economic Development Council | Regional Incubation Center for Life Science Initiatives | $75,000 | FY 2014 | Completed |
Capital Program | North Shore Biotech Consortium | Life Sciences Consortium of the North Shore | $5,000,000 | FY 2014 | Completed |
Workforce Capital | North Shore Biotech Consortium | Enhancing the Life Sciences Workforce Pipeline in the North of Boston Region | $1,630,686 | FY 2022 | Completed |
Capital Program | North Shore InnoVentures | NSIV Expansion | $1,500,000 | FY 2019 | Completed |
Capital Program | North Shore InnoVentures | Nurturing Strengths and Building Opportunities in Metro-North's Life Science Community | $3,100,000 | FY 2022 | Completed |
Capital Program | Northeastern University | Biopharma Analysis Training Lab | $4,271,867 | FY 2019 | Completed |
NIIMBL | Northeastern University | Modularized PAT Online Training Platform to Accelerate the Workforce Innovation in Biopharmaceuticals Manufacturing | $374,391 | FY 2021 | Completed |
Novel Therapeutics Delivery | Northeastern University | CNS Delivery of Nucleic Acid Therapeutics using MIND | $749,858 | FY 2021 | Completed |
Bits to Bytes | Northeastern University | Understanding macrophage polarization by data-driven single-cell proteomics | $780,000 | FY 2022 | Completed |
NIIMBL | Northeastern University | Advanced Bioprocess Sensor and Analytical Technologies for Induced Pluripotent Stem Cell Culture Online Monitoring and Automation | $370,970 | FY 2023 | Completed |
Women's Health Innovation | Northeastern University | InCITE: A Biomaterial Platform to Overcome Barriers to Drug Delivery (ovarian cancer) | $200,000 | FY 2024 | *Ongoing |
Bits to Bytes | Northeastern University | In Silico design of an arrary chromophores | $749,968 | FY 2019 | Completed |
Research Infrastructure | Northeastern University | Infrastructural Support to Establish Single-Cell Proteomics Facility at Northeastern University | $2,196,702 | FY 2025 | *Ongoing |
Capital Program | Northern Essex Community College | Haverhill and Lawrence Labs | $1,242,000 | FY 2013 | Completed |
Workforce Capital | Nubian Square Ascends | NuSq Life Science Training Center | $1,446,999 | FY 2023 | Completed |
Capital Program | Pittsfield Economic Development Authority | Planning Grant | $55,000 | FY 2013 | Completed |
Capital Program | Quincy College | Workforce Training in Biomanufacturing: Upstream & Downstream Processing | $725,739 | FY 2019 | Completed |
NIIMBL | Quincy College | Equipment and supplies needed to support new gene and cell therapy training. | $49,928 | FY 2020 | Completed |
Workforce Development Capital | Quincy College | Industry-aligned Certificate and Degree Program for Training Skilled Workforce in Biomanufacturing | $641,652 | FY 2024 | *Ongoing |
Capital Program | Quincy College | Equipment for Workforce Training | $78,799 | FY 2013 | Completed |
Capital Program | Quincy College | Equipment for Workforce Training | $499,872 | FY 2014 | Completed |
Workforce Capital | Quincy College | Biomanufacturing Industry-Aligned Certificate and Degree | $726,958 | FY 2022 | Completed |
NIIMBL | Quincy College | Equipment and supplies to support life sciences education and training | $458,912 | FY 2023 | Completed |
Workforce Development Capital | Quinsigamond Community College | Science Lab Update | $385,476 | FY 2025 | *Ongoing |
Capital Program | Quinsigamond Community College | Equipment for Workforce Training | $310,000 | FY 2013 | Completed |
Capital Program | Quinsigamond Community College | Equipment for Workforce Training | $499,880 | FY 2014 | Completed |
Capital Program | Quinsigamond Community College | Capital and Equipment | $4,999,998 | FY 2015 | Completed |
Workforce Development Capital | Regis College | Enhancing Laboratory Management for Life Sciences Workforce | $746,476 | FY 2024 | Completed |
Capital Program | Regis College | Planning Grant | $50,000 | FY 2013 | Completed |
Capital Program | Regis College | Equipment for Workforce Training | $355,000 | FY 2015 | Completed |
Workforce Capital | Roxbury Community College | Biotechnology and Biological Science | $222,153 | FY 2023 | Completed |
Workforce Development Capital | Roxbury Community College | Support Request for Biological Science (AS)(C) and Biotechnology (AS)(C) Programs | $331,048 | FY 2024 | *Ongoing |
Capital Program | Roxbury Community College | Capital and Equipment | $3,000,000 | FY 2015 | Completed |
Capital Program | Smith College | Equipment - Center for Molecular Biology, Microscopy & Imaging | $489,435 | FY 2017 | Completed |
Workforce Development Capital | Smith College | Empowering Women in the Life Sciences Workforce: Advanced Training Through the Integration of NMR Spectroscopy | $555,232 | FY 2024 | *Ongoing |
Capital Program | Springfield Technical Community College | Planning Grant | $85,673 | FY 2013 | Completed |
Capital Program | Springfield Technical Community College | Biomedical Engineering Lab | $972,850 | FY 2015 | Completed |
Capital Program | The Forsyth Institute | Forsyth Center for Salivary Diagnostics (FCSD) | $4,133,215 | FY 2013 | Completed |
Capital Program | The Forsyth Institute | Host Microbiome Center | $2,210,229 | FY 2015 | Completed |
Capital Program | The Mansfield Bio-Incubator | Bio-incubator Laboratory infrastructure expansion project | $2,000,000 | FY 2020 | Completed |
Capital Program | Tufts-Cummings School of Veterinary Medicine | School of Veterinary Medicine (NE-RBL) | $9,500,000 | FY 2009 | Completed |
Bits to Bytes | Tufts University | Noninvasive detection of bladder cancer through advanced nanoscale imaging and machine learning analysis | $749,937 | FY 2021 | Completed |
Capital Program | Tufts University | Establishing a state of the art comparative infectious disease pathology core to accelerate translational research | $2,027,244 | FY 2021 | Completed |
Novel Therapeutics Delivery | Tufts University | Transdermal delivery of monoclonal antibody therapy using macro-porous structured hard microneedle technology | $745,403 | FY 2021 | Completed |
Women's Health | Tufts University | Elucidating sex differences in network aberrations in depression while building equitable infrastructure for research | $251,507 | FY 2021 | Completed |
Bits to Bytes | Tufts University | Advancing animal models of disease with spatial multi-omics and quantitative image analysis | $750,000 | FY 2023 | Completed |
Novel Therapeutics Delivery | Tufts University | Brain delivery of mRNA using neurotransmitter derived lipid nanoparticles | $498,603 | FY 2023 | Completed |
Women's Health Innovation | Tufts University | A Smart Garment for Women’s Health Monitoring | $174,979 | FY 2023 | Completed |
Women's Health Innovation | Tufts University | Real-Time, Colorimetric Sensing Wearable Product and App Design for the Diagnosis and Long-Term Management of Bacterial Vaginosis | $100,000 | FY 2023 | Completed |
Novel Therapeutics Delivery | Tufts University | Characterization of Protein-Based Nanoparticles for Life Science Needs | $373,460 | FY 2024 | Completed |
Women's Health Innovation | Tufts University | Novel imaging modality and image analysis to decrease the number of unnecessary colposcopies during screening for cervical cancer | $200,000 | FY 2024 | *Ongoing |
Women's Health Innovation | Tufts University | Benchtop Testing of a Medical Device to Treat Cervical Insufficiency | $200,000 | FY 2024 | *Ongoing |
Women's Health Innovation | Tufts University | NeurOsis: An Innervated Physiomimetic Platform for Modelling Neuroinflammation in Endometriosis | $200,000 | FY 2025 | *Ongoing |
Capital Program | UMass Amherst | Acquisition of Synapt G2-32k Mass Spectrometer for biopharmaceutical | $299,329 | FY 2020 | Completed |
Capital Program | UMass Amherst | Enhancement of the UMass Amherst Light Microscopy Facility for cutting edge | $515,617 | FY 2020 | Completed |
Capital Program | UMass Amherst | SampleJet, high throughput sample changing roboto for NMR | $129,900 | FY 2020 | Completed |
Capital Program | UMass Amherst | MLSC Open Capital Flow Cytometry at UMass Amherst | $1,100,259 | FY 2020 | Completed |
Women's Health | UMass Amherst | Artificial Intelligence for Menopause Symptoms (AIMS) | $747,107 | FY 2020 | Completed |
Capital Program | UMass Amherst | Life Sciences Laboratory Research Center Complex | $95,000,000 | FY 2013 | Completed |
Women's Health Innovation | UMass Amherst | Thermal therapeutic to regulate sleeping in menopausal women | $199,911 | FY 2021 | Completed |
Capital Program | UMass Amherst | Provide a cryo-transmission electron microscope facility for Western Massachusetts | $1,655,774 | FY 2023 | Completed |
Capital Program | UMass Amherst | Expand light microscopy offerings to enhance biomedical training and research | $1,554,994 | FY 2023 | Completed |
Research Infrastructure | UMass Amherst | UMass Amherst 800 MHz NMR for structural biology, metabolomics and workforce development | $4,416,301 | FY 2024 | Completed |
Research Infrastructure | UMass Amherst | timsTOF fleX for quantitative proteomics, imaging, metabolomics and workforce development | $1,985,000 | FY 2025 | *Ongoing |
Research Infrastructure | UMass Amherst | Advancing Micro/Nano-Fabrication and Characterization Capabilities to Drive Biomedical Device Innovation and Research in Western Massachusetts | $1,585,877 | FY 2025 | *Ongoing |
Bits to Bytes | UMass Boston | The Oregon-Massachusetts Mammography Database (OMAMA-DB) | $749,834 | FY 2020 | Completed |
Capital Program | UMass Boston | Profile gene expression using spatial transcriptomics | $1,062,681 | FY 2023 | Completed |
Novel Therapeutics Delivery | UMass Boston | Characterization of Protein-Based Nanoparticles for Life Science Needs | $338,264 | FY 2024 | *Ongoing |
Capital Program | UMass Boston | Conversion of Venture Development Center (VDC) | $588,848 | FY 2014 | Completed |
Capital Program | UMass Boston | NextGen Sequencing at the Next Level: UMass Boston CPCT Genomic Core | $387,808 | FY 2020 | Completed |
Bits to Bytes | UMass Boston | Development of a bispecific antibody for treatment of tumors that targets EGFR, NRP1 and resistant to heparin binding | $749,965 | FY 2022 | Completed |
Capital Program | UMass Boston | Biophysical Instrumentation Core for Molecular Interactions, Thermodynamics, and Structure for Life Sciences | $1,647,201 | FY 2022 | Completed |
Workforce Development Capital | UMass Boston | Immersive Mentored Practicum for AI Career Training (IMPACT) | $538,013 | FY 2025 | *Ongoing |
Workforce Development Capital | UMass Boston | Strengthening Undergraduate Life Sciences Training | $748,758 | FY 2025 | *Ongoing |
Capital Program | UMass Boston | Center for Personalized Cancer Therapy (CPCT) | $9,878,503 | FY2011/ FY2014 | Completed |
Capital Program | UMass Chan Medical School | Albert Sherman Center | $90,000,000 | FY 2010 | Completed |
Capital Program | UMass Chan Medical School | Titan Krios Microscope for the MACryoEM | $5,000,000 | FY 2015 | Completed |
Bits to Bytes | UMass Chan Medical School | AI in high resolution neurovascular imaging | $750,000 | FY 2019 | Completed |
Bits to Bytes | UMass Chan Medical School | Spatial transcriptomic approaches to map neuroinflammation in neurodegenerative disease | $742,818 | FY 2020 | Completed |
Capital Program | UMass Chan Medical School | UMass Chan Medical School Positron Emission Tomography Center | $1,370,315 | FY 2020 | Completed |
Capital Program | UMass Chan Medical School | Enhancing Innovation in Drug Discovery at UMass Chan Medical School | $926,305 | FY 2020 | Completed |
Women's Health | UMass Chan Medical School | Improving Breast Cancer Diagnosis Using Artificial Intelligence in Mammography Screenings | $750,000 | FY 2020 | Completed |
Women's Health | UMass Chan Medical School | Breast Cancer Detection Empowered by Contrast Agents, Spectral CT, and Machine Learning | $150,225 | FY 2020 | Completed |
Capital Program | UMass Chan Medical School | Massachusetts Center for High-Resolution Electron Cryomicroscopy | $2,797,610 | FY 2021 | Completed |
Capital Program | UMass Chan Medical School | Enabling nanoscale imaging of viruses of pandemic potential at UMCMS | $2,017,040 | FY 2022 | Completed |
Capital Program | UMass Chan Medical School | Establish the Massachusetts NMR Consortium | $2,331,572 | FY 2023 | Completed |
Women's Health Innovation | UMass Chan Medical School | Developing TAS2R-based therapeutics for preterm birth management | $200,000 | FY 2023 | Completed |
Bits to Bytes | UMass Chan Medical School | Expanding into 3 dimensions: a new spatial -omics technology at UMass Chan | $800,000 | FY 2024 | *Ongoing |
Women's Health Innovation | UMass Chan Medical School | Increasing health equity with point of care diagnosis for cervical, and vulvar cancer | $200,000 | FY 2025 | *Ongoing |
Capital Program | UMass Dartmouth | Massachusetts Accelerator for Biomanufacturing (MAB) | $20,600,000 | FY 2012 | Completed |
Capital Program | UMass Dartmouth | Advanced Technology Manufacturing Center (ATMC) | $11,400,000 | FY 2012 | Completed |
Workforce Capital | UMass Dartmouth | Stepping Stones: Achieving Greater Diversity in Life Sciences through Laboratory Science | $748,953 | FY 2022 | Completed |
Workforce Capital | UMass Dartmouth | Biomanufacturing Training Program | $352,855 | FY 2023 | Completed |
Workforce Development Capital | UMass Dartmouth | SouthCoast Biomanufacturing Training Program | $737,449 | FY 2024 | *Ongoing |
Capital Program | UMass Lowell | Perry Hall build out for BME Program Laboratories | $5,000,000 | FY 2017 | Completed |
NIIMBL | UMass Lowell | Lyophilization Scale-up | $1,000,000 | FY 2018 | Completed |
NIIMBL | UMass Lowell | Bioreactor Trace Meal Quantification | $246,754 | FY 2018 | Completed |
Building Breakthroughs | UMass Lowell | Integrated Continuous Biopharma Manufacturing | $637,601 | FY 2019 | Completed |
NIIMBL | UMass Lowell | Lyophilization Scale-up (Additional funding) | $299,779 | FY 2019 | Completed |
NIIMBL | UMass Lowell | Developing a Fluorescence-based Multi-step IEX-HPLC Method for Quantification of Capsid in AAV products | $216,090 | FY 2021 | Completed |
Workforce Development Capital | UMass Lowell | Advanced Biomedical Histology and Cell Culture Facility | $749,825 | FY 2025 | *Ongoing |
Capital Program | UMass Lowell | Emerging Technologies and Innovation Center (ETIC) | $10,000,000 | FY 2012 | Completed |
Capital Program | UMass Lowell | Big Company/Little Company (M2D2 Innovation Hub) | $5,046,592 | FY 2014 | Completed |
Capital Program | UMass Lowell | Establishing a public small animal imaging core research facility for Northeast Massachusetts | $1,132,949 | FY 2020 | Completed |
Women's Health | UMass Lowell | Breast Cancer Detection Empowered by Contrast Agents, Spectral CT, and Machine Learning | $590,496 | FY 2020 | Completed |
Workforce Capital | UMass Lowell | Biomanufacturing Workforce Development Program | $644,451 | FY 2022 | Completed |
NIIMBL | UMass Lowell | Advanced Bioprocess Sensor and Analytical Technologies for Induced Pluripotent Stem Cell Culture Online Monitoring and Automation | $353,000 | FY 2023 | Completed |
NIIMBL | UMass Lowell | Integrated Continuous USP Platform for Maximum Productivity and Closed-loop controlled CQA | $681,057 | FY 2023 | Completed |
Women's Health Innovation | UMass Lowell | Got milk? Harnessing human milk as a liquid biopsy to diagnose lactation disorders | $120,357 | FY 2023 | Completed |
Workforce Capital | UMass Lowell | Pathogen Diagnostics Certificate Program | $746,596 | FY 2023 | Completed |
Research Infrastructure | UMass Lowell | Advanced Liquid Chromatography Mass - Spectrometer for State-of-the-art Proteomics Applications in Life Sciences at UMass Lowell | $1,321,200 | FY 2024 | *Ongoing |
Workforce Development Capital | UMass Lowell | Biology Workforce-Based Curriculum and Laboratory Modernization Project | $749,907 | FY 2024 | *Ongoing |
Workforce Development Capital | UMass Lowell-Bioversity | Bioversity Merrimack Valley | $658,527 | FY 2024 | *Ongoing |
Workforce Development Capital | Urban College of Boston | Science Simulation Laboratory & Curriculum Program | $122,542 | FY 2024 | *Ongoing |
Capital Program | Venture Cafe | Capital Improvements to District Hall | $347,000 | FY 2014 | Completed |
Capital Program | Wellesley College | Planning Grant - Renovation of Life Sciences Center | $49,376 | FY 2015 | Completed |
Workforce Development Capital | Wentworth Institute of Technology | Synthetic-biology Proficiency, Outreach, and Talent Source (SPOTS) | $497,630 | FY 2024 | Completed |
Workforce Development Capital | Wentworth Institute of Technology | SHINE: Strategic, Hands-on, Immersive, Novel, and Experiential Program for Workforce Training | $724,951 | FY 2025 | *Ongoing |
Workforce Development Capital | Wentworth Institute of Technology | Integrating Biotechnology into G2 General Chemistry II Lab | $105,723 | FY 2025 | *Ongoing |
Workforce Development Capital | Western New England University | Master of Science in Pharmaceutical Engineering | $499,518 | FY 2024 | Completed |
Workforce Development Capital | Western New England University | M.S. in Biopharmaceutical Technology | $249,368 | FY 2025 | *Ongoing |
Capital Program | Western New England University | Equipment for Workforce Training | $497,449 | FY 2014 | Completed |
Capital Program | Westfield State University | Planning Grant - Center for Biotechnology at WSU | $43,564 | FY 2017 | Completed |
Women's Health | Westfield State University | Predictive modeling to create "bioprofiles": for use in personalized medicine in women's health | $491,905 | FY 2020 | Completed |
Workforce Development Capital | Westfield State University | GEAR UP: Gaining Experience with Advanced Resources for Undergraduate Proficiency in STEM | $453,957 | FY 2025 | *Ongoing |
Workforce Development Capital | Williams College | Big Brains, Big Data, Big Impact: Hands-On Data Science Training for Undergraduates in the Life Sciences | $744,446 | FY 2024 | Completed |
Building Breakthroughs | Worcester Polytechnic Institute | Recombinant Adeno-Associated Virus | $566,815 | FY 2019 | Completed |
Capital Program | Worcester Polytechnic Institute | Cell Engineering Research Accelerator @ WPI | $877,314 | FY 2020 | Completed |
Women's Health Innovation | Worcester Polytechnic Institute | Increase understanding of maternal-fetal interface through lipid-based models | $135,316 | FY 2021 | Completed |
Workforce Capital | Worcester Polytechnic Institute | Strengthening and Expanding BETC Workforce Engagement | $720,603 | FY 2022 | Completed |
Bits to Bytes | Worcester Polytechnic Institute | Development of a robust strategy for production of vaccine adjuvants in Quillaja saponaria plant cell suspension culture | $750,510 | FY 2024 | *Ongoing |
Capital Program | Worcester Polytechnic Institute | Biomanufacturing Education and Training Center (BETC) | $5,149,999 | FY 2010 | Completed |
NIIMBL | Worcester Polytechnic Institute | SPIDER Project | $139,984 | FY 2018 | Completed |
NIIMBL | Worcester Polytechnic Institute | Blended Learning Cell Therapy Course | $262,267 | FY 2018 | Completed |
Workforce Development Capital | Worcester Polytechnic Institute | Advancing BioProcess Innovation and Education in the Dept. of Biology and Biotechnology | $625,000 | FY 2025 | *Ongoing |
Workforce Development Capital | Worcester Polytechnic Institute | Evolving BETC to a Biomanufacturing Excellence and Training Center | $625,000 | FY 2025 | *Ongoing |
Workforce Development Capital | Worcester Polytechnic Institute | CellTech Academy: From Training to Discovery | $730,994 | FY 2025 | *Ongoing |
Workforce Capital | Worcester State University | Collaborative Teaching Methods (CoTEAM) to Enhance Life Sciences Workforce Development | $652,689 | FY 2022 | Completed |
Novel Therapeutics Delivery | Wyss Institute at Harvard | New targets and novel antibody shuttles for brain delivery of therapeutics | $749,956 | FY 2020 | Completed |
Novel Therapeutics Delivery | Wyss Institute at Harvard | Advancing brain shuttles toward IND through NHP studies and optimization for diverse drug types | $750,000 | FY 2024 | *Ongoing |
| | Total | $672,685,212 | | |